FROM 01 Oct pharmacists will
need a referral from a GP to
conduct a Residential Medication
Management Review.
And from the same date, all
RMMR Service Agreements which
include associated QUM Services
will be terminated by Medicare
Australia or the Health Dept.
The move follows last year’s
Campbell Research review of the
RMMR scheme, which concluded
that better outcomes were
achieved using a collaborative
approach, despite this leading to a
higher cost per review.The above article was sent to subscribers in Pharmacy Daily's issue from 03 Aug 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Aug 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.